Owner Novo Nordisk Health Care AG

Inventors Pingel, Hans Kurt; Klausen, Niels Kristian

Agent Shelston IP

Pub. Number AU-B-2001291652

PCT Pub. Number WO02/29025

Priority 60/238,944 10.10.00 US; 60/271,581 26.02.01 US; 60/276,322 16.03.01 US; PA 2001 00751 14.05.01 DK; PA 2001 00262 16.02.01 DK; PA 2000 01456 02.10.00 DK; PA 2001 00430 14.03.01 DK

Filing date 2 October 2001

Wipo publication date 15 April 2002

Acceptance publication date 13 September 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms